Clinical Trials Sponsored by Endocare, Inc.

Total 35641 results

Emory University
Endocare, Inc.

Completed

Cryoablation for Obesity Management

Obesity

United States
InnoCare Pharma Inc.

Not yet recruiting

Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of ICP-248 in Mature B-cell Malignancies

Mature B-cell Malignancies
InnoCare Pharma Inc.

Not yet recruiting

A Global Phase 3 Study of Orelabrutinib+BR vs.BR in Pts With TN MCL

Mantle Cell Lymphoma
InnoCare Pharma Inc.

Active, not recruiting

Evaluate the Safety, Tolerability, and Pharmacokinetics of ICP-723 in Patients With Advanced Solid Tumors

Advanced Solid Tumors

United States
University of Minnesota
Endocare, Inc.; Manoj, Monga, M.D.

Completed

Evaluating the Effect of the VCD on Erectile Function and Penile Length Post RRP

Prostatic Neoplasms | Prostatectomy

United States
InnoCare Pharma Inc.
Beijing InnoCare Pharma Tech Co., Ltd.

Recruiting

Evaluating Different Doses of Orelabrutinib in MCL

Mantle Cell Lymphoma

China
Endocyte

Recruiting

Study of 225Ac-PSMA-617 in Men With PSMA-positive Prostate Cancer

Prostatic Neoplasms, Castration-Resistant

Australia, South Africa
Endocyte

Completed

Study of 177Lu-PSMA-617 In Metastatic Castrate-Resistant Prostate Cancer (VISION)

Prostate Cancer

United States, United Kingdom, Canada, Netherlands, Sweden, France, Puerto Rico, Belgium, Denmark, Germany
Endocyte

Completed

Safety and Biodistribution of Technetium Tc 99m EC20 in Normal Volunteers and Ovarian Cancer Patients

Ovarian Cancer | Healthy Volunteers

United States
Endocyte

Terminated

Study for Women With Platinum Resistant Ovarian Cancer Evaluating EC145 in Combination With Doxil® (PROCEED) (PROCEED)

Ovarian Cancer
Endocyte

Completed

Phase 2 Study of EC145 Alone Versus EC145+Docetaxel Versus Docetaxel Alone in Participants With FR(++) 2nd Line Non Small Cell Lung Cancer (TARGET)

Non Small Cell Lung Cancer
Endocyte

Completed

Folic Acid-Tubulysin Conjugate EC1456 In Patients With Advanced Solid Tumors

Solid Tumors | Non Small Cell Lung Carcinoma

United States
Endocyte

Completed

Phase 1 of EC1169 In Patients With Recurrent MCRPC

Prostate Cancer

United States
Endocyte

Terminated

A Study of MK-8109 (Vintafolide) Given Alone or With Chemotherapy in Participants With Advanced Cancers (MK-8109-001)

Advanced Cancer
Endocyte

Completed

Platinum Resistant Ovarian Cancer Evaluation of Doxil and Vintafolide (MK-8109, EC145) Combination Therapy (8109-009, EC-FV-04) (PRECEDENT)

Ovarian Cancer
Endocyte

Completed

Evaluation of the Biodistribution and Safety of 99mTC-Etarfolatide (EC20) in Normal Volunteers

Healthy

United States
Endocyte

Completed

Study of EC0225 for the Treatment of Refractory or Metastatic Tumors

Cancer

United States
Endocyte

Completed

Safety and Efficacy of FalateScan (Technetium Tc 99m EC20) in Patients With Known Suspected Recurrent or Metastatic Cancer From a Solid Tumor

Head and Neck Cancer | Bladder Cancer | Pancreas Cancer | Testicular Cancer | Recurrent or Metastatic Cancer
Endocyte

Completed

Safety and Efficacy of FolateScan (Technetium Tc 99m EC20) in Women With Suspected Ovarian or Endometrial Cancer

Ovarian Cancer | Endometrial Cancer

United States
Endocyte

Completed

Safety and Efficacy of FolateScan (Technetium Tc 99m EC20) in Subjects With Suspected Metastatic Renal Cell Carcinoma

Metastatic Renal Cell Carcinoma

United States
Endocyte

Completed

Radiolabeled Folic Acid and Imaging to Detect Ovarian Cancer

Ovarian Cancer

United States
Endocyte

Completed

Study of Vintafolide (MK-8109, EC145) in Participants With Progressive Adenocarcinoma of the Lung (MK-8109-008, EC-FV-03)

Adenocarcinoma of the Lung
Endocyte

Terminated

A Study of Vintafolide (MK-8109) in Participants With Advanced Solid Tumor (MK-8109-011)

Solid Tumor
Endocyte

Completed

Study of Vintafolide (MK-8109, EC145) for the Treatment of Recurrent or Refractory Solid Tumors (MK-8109-006, EC-FV-01)

Cancer

United States
Endocyte

Terminated

A Phase II Study of EC17 (Folate-hapten Conjugate) in Patients With Progressive Metastatic Renal Cell Carcinoma

Renal Cell Carcinoma

United States
Endocyte

Completed

Study Using FolateScan to Identify Subjects With Folate Receptor-Positive Metastatic Renal Cell Carcinoma

Metastatic Renal Cell Carcinoma

United States
Endocyte

Completed

Safety and Efficacy of Folatescan (Technetium TC 99M EC20) in Patients With Suspected Ovarian Carcinoma or Recurrent Endometrial Carcinoma

Recurrent Endometrial Carcinoma | Ovarian Carcinoma
Endocyte

Completed

Safety and Efficacy of FolateScan (Technetium Tc 99m EC20) in Subjects With Pituitary Tumors

Pituitary Tumors

United States
Endocyte

Completed

Extension Study of EC145 (Vintafolide) for Subjects Enrolled in a Previous Study With EC145 (MK-8109-010)

Solid Tumors

United States
Endocyte

Terminated

Lutetium-177 (Lu177) Prostate-Specific Antigen (PSMA)-Directed EndoRadiotherapy (RESIST-PC)

Metastatic Castration Resistant Prostate Cancer

United States
Endocyte

Completed

An Exploratory Study of the Folic Acid-tubulysin Conjugate EC1456 in Ovarian Cancer Subjects Undergoing Surgery

Ovary Cancer

Canada, United States
Endocyte

Completed

Study of Vintafolide (MK-8109, EC145) in Participants With Advanced Ovarian and Endometrial Cancers (MK-8109-007, EC-FV-02)

Ovarian Cancer | Endometrial Cancer
Endocyte

Withdrawn

Safety and Efficacy Study of Vintafolide and Vintafolide Plus Paclitaxel Compared to Paclitaxel Alone in Participants With Triple Negative Breast Cancer (TNBC) (MK-8109-004)

Breast Neoplasms
Endocyte

Completed

Study of EC0489 for the Treatment of Refractory or Metastatic Tumors

Cancer

United States
Endocyte

Completed

Safety and Tolerability Study of FolateImmune in Combination With Cytokines in Patients With Refractory or Metastatic Cancer

Cancer

United States
EndoCore Lab s.r.l.

Recruiting

Peripheral Extreme Revascularization in "No-option" Patiens With Chronic Limb Threatening Ischemia (PiPER)

Diabetic Foot | Peripheral Arterial Disease | Critical Limb-Threatening Ischemia

Italy
Wake Forest University Health Sciences
National Cancer Institute (NCI); Endocare, Inc.

Terminated

Cryosurgery and Radiation Therapy in Treating Patients With Painful Bone Metastases

Pain | Bone Metastases

United States
Ludocare SAS
Clinact

Active, not recruiting

Evaluation of Efficacy and Tolerance of JOE on 4 to 11 Years Old Asthmatic Patients of GINA 2,3,4 and 5 Grades (JoeCare)

Asthma in Children

France
Mayo Clinic
Endocyte

Completed

FolateScan in Autoimmune Disease

Multiple Sclerosis | Osteoarthritis | Rheumatoid Arthritis | Systemic Lupus Erythematosus | Crohn's Disease

United States
EndoCore Lab s.r.l.
Fondazione Italiana Vascolare

Recruiting

Use of Shockwave M5+ IVL Catheter (Intravascular Lithotripsy) in Hostile and Calcified Iliac Access (SHOCK-ACCESS)

Peripheral Arterial Disease | Aortic Diseases | Aorto-Iliac Atherosclerosis

Italy
M.D. Anderson Cancer Center
Gen-Probe, Incorporated; Endocare, Inc.; FirmaMed; Envisioneering Medical Technologies

Completed

Prostate Conformal Cryotherapy

Prostate Cancer

United States
EndoCore Lab s.r.l.
Fondazione Italiana Vascolare

Recruiting

Shockwave ®S4 Catheter IVL to Treat Infrapopliteal Calcified Stenoses and/or Occlusions in CLTI Patients (LEGACY) (LEGACY)

Peripheral Arterial Disease | Critical Limb-Threatening Ischaemia

Italy
EndoCore Lab s.r.l.
Fondazione Italiana Vascolare

Completed

SUPERa Stenting After SUBintimal Crossing of TASC C-D Femoro-popliteal Lesions in CLI Patients (SUPERSUBII)

PAD

United States, Argentina, Italy, United Kingdom
Innocare Pharma Australia Pty Ltd

Completed

A Phase I Study of ICP-022 in Healthy Subjects

Rheumatoid Arthritis | Systemic Lupus Erythematosus

Australia
Vanderbilt University Medical Center
Endocyte

Terminated

Imaging Activated Macrophages in the Lungs

COPD

United States
Beijing InnoCare Pharma Tech Co., Ltd.

Recruiting

Evaluate the Efficacy and Safety of Orelabrutinib in Adult Patients With Chronic Primary Immune Thrombocytopenia

Chronic Primary Immune Thrombocytopenia (ITP)

China
Beijing InnoCare Pharma Tech Co., Ltd.

Recruiting

Evaluate the Safety, Tolerability, and Efficacy of ICP-490 in Patients With Relapsed and/or Refractory Multiple Myeloma

Relapsed and/or Refractory Multiple Myeloma

China
Beijing InnoCare Pharma Tech Co., Ltd.

Recruiting

Study to Evaluate Orelabrutinib Tablets in Subjects With Hepatic Impairment and Healthy Subject

Hepatic Impairment

China
Beijing InnoCare Pharma Tech Co., Ltd.

Recruiting

A Study of ICP-192 in Patients With FGFR2-Rearranged Unresectable or Metastatic Intrahepatic Cholangiocarcinoma

Intrahepatic Cholangiocarcinoma (ICC)

China
Beijing InnoCare Pharma Tech Co., Ltd.

Recruiting

A Clinical Trial of ICP-192 in Treated Patients With Advanced Solid Tumors With FGF/FGFR Gene Alterations

Advanced Solid Tumor

China

3

Subscribe